CVE-2026-118468
Full vulnerability record from the local CVENow database.
Description
XML parsers process attacker-influenced update manifests or network responses with external entity resolution enabled, potentially allowing XML External Entity (XXE) attacks.
Severity
HIGH
CVSS score
7.2
(v4.0)
Vulnerability status
Received
Source identifier
a6d3dc9e-0591-4a13-bce7-0f5b31ff6158
Published
2026-11-09 12:16:37.710000
Last modified
2026-11-09 12:16:37.710000
View original CVE JSON
{
"id": "CVE-2026-118468",
"sourceIdentifier": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"published": "2026-11-09T12:16:37.710",
"lastModified": "2026-11-09T12:16:37.710",
"vulnStatus": "Received",
"cveTags": [],
"descriptions": [
{
"lang": "en",
"value": "XML parsers process attacker-influenced update manifests or network responses with external entity resolution enabled, potentially allowing XML External Entity (XXE) attacks."
}
],
"affected": [
{
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"affectedData": [
{
"vendor": "CompuGroup Medical",
"product": "Infantia",
"defaultStatus": "unaffected",
"versions": [
{
"version": "0",
"lessThanOrEqual": "6.01.1",
"versionType": "semver",
"status": "affected"
}
]
},
{
"vendor": "CompuGroup Medical",
"product": "Profim",
"defaultStatus": "unaffected",
"versions": [
{
"version": "0",
"lessThanOrEqual": "6.01.1",
"versionType": "semver",
"status": "affected"
}
]
},
{
"vendor": "CompuGroup Medical",
"product": "Phronesis",
"defaultStatus": "unaffected",
"versions": [
{
"version": "0",
"lessThanOrEqual": "4.51.0",
"versionType": "semver",
"status": "affected"
}
]
},
{
"vendor": "CompuGroup Medical",
"product": "Venere",
"defaultStatus": "unaffected",
"versions": [
{
"version": "0",
"lessThanOrEqual": "8.33.2",
"versionType": "semver",
"status": "affected"
}
]
}
]
}
],
"metrics": {
"cvssMetricV40": [
{
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"type": "Secondary",
"cvssData": {
"version": "4.0",
"vectorString": "CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X",
"baseScore": 7.2,
"baseSeverity": "HIGH",
"attackVector": "NETWORK",
"attackComplexity": "HIGH",
"attackRequirements": "PRESENT",
"privilegesRequired": "NONE",
"userInteraction": "NONE",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnAvailabilityImpact": "HIGH",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"subAvailabilityImpact": "NONE",
"exploitMaturity": "UNREPORTED",
"confidentialityRequirement": "NOT_DEFINED",
"integrityRequirement": "NOT_DEFINED",
"availabilityRequirement": "NOT_DEFINED",
"modifiedAttackVector": "NOT_DEFINED",
"modifiedAttackComplexity": "NOT_DEFINED",
"modifiedAttackRequirements": "NOT_DEFINED",
"modifiedPrivilegesRequired": "NOT_DEFINED",
"modifiedUserInteraction": "NOT_DEFINED",
"modifiedVulnConfidentialityImpact": "NOT_DEFINED",
"modifiedVulnIntegrityImpact": "NOT_DEFINED",
"modifiedVulnAvailabilityImpact": "NOT_DEFINED",
"modifiedSubConfidentialityImpact": "NOT_DEFINED",
"modifiedSubIntegrityImpact": "NOT_DEFINED",
"modifiedSubAvailabilityImpact": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"valueDensity": "NOT_DEFINED",
"vulnerabilityResponseEffort": "NOT_DEFINED",
"providerUrgency": "NOT_DEFINED"
}
}
]
},
"weaknesses": [
{
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"type": "Secondary",
"description": [
{
"lang": "en",
"value": "CWE-611"
}
]
}
],
"references": [
{
"url": "https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical",
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158"
},
{
"url": "https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html",
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158"
}
]
}